Embla Medical (Össur) – Presentation of Interim report Q1 2024

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

Embla Medical (Össur) will release its Q1 2024 report on 23 April 2024. The company’s management will present the results in a virtual live event with a Q&A session on 24 April 2024 at 14:00. Besides the financial results, you can get an update on recent business developments.

Guidance for 2024 is an organic sales growth of 5-8%, which is expected to be driven by continued volume growth and moderate price increases. EBITDA margin before special items guidance is 19-20%, driven by expectations of a favorable product mix, increased efficiency in manufacturing, and scalability.

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and Patient Care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.

Dislcaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 14:55, 22 March 2024.